MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells
about
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
P2860
MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
MLS-2384, a new 6-bromoindirub ...... growth of diverse cancer cells
@en
MLS-2384, a new 6-bromoindirub ...... rowth of diverse cancer cells.
@nl
type
label
MLS-2384, a new 6-bromoindirub ...... growth of diverse cancer cells
@en
MLS-2384, a new 6-bromoindirub ...... rowth of diverse cancer cells.
@nl
prefLabel
MLS-2384, a new 6-bromoindirub ...... growth of diverse cancer cells
@en
MLS-2384, a new 6-bromoindirub ...... rowth of diverse cancer cells.
@nl
P2093
P2860
P356
P1476
MLS-2384, a new 6-bromoindirub ...... growth of diverse cancer cells
@en
P2093
Leandros Skaltsounis
Nicolas Gaboriaud
Richard Jove
P2860
P304
P356
10.4161/CBT.26721
P577
2013-11-01T00:00:00Z